CN101581726B - 新一代布鲁氏菌病抗体竞争酶联免疫吸附试验检测试剂盒 - Google Patents
新一代布鲁氏菌病抗体竞争酶联免疫吸附试验检测试剂盒 Download PDFInfo
- Publication number
- CN101581726B CN101581726B CN 200910071634 CN200910071634A CN101581726B CN 101581726 B CN101581726 B CN 101581726B CN 200910071634 CN200910071634 CN 200910071634 CN 200910071634 A CN200910071634 A CN 200910071634A CN 101581726 B CN101581726 B CN 101581726B
- Authority
- CN
- China
- Prior art keywords
- serum
- preparation
- antibody
- brucellosis
- bottle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 53
- 206010006500 Brucellosis Diseases 0.000 title claims abstract description 51
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 20
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 20
- 238000001514 detection method Methods 0.000 title abstract description 36
- 239000003547 immunosorbent Substances 0.000 title abstract description 12
- 238000001179 sorption measurement Methods 0.000 title abstract description 12
- 210000002966 serum Anatomy 0.000 claims abstract description 128
- 102000036639 antigens Human genes 0.000 claims abstract description 58
- 108091007433 antigens Proteins 0.000 claims abstract description 58
- 239000000427 antigen Substances 0.000 claims abstract description 57
- 241001465754 Metazoa Species 0.000 claims abstract description 52
- 238000000034 method Methods 0.000 claims abstract description 29
- 239000000243 solution Substances 0.000 claims abstract description 29
- 241000589562 Brucella Species 0.000 claims abstract description 25
- 239000007788 liquid Substances 0.000 claims abstract description 21
- 239000000758 substrate Substances 0.000 claims abstract description 16
- 238000005406 washing Methods 0.000 claims abstract description 15
- 239000013641 positive control Substances 0.000 claims abstract description 10
- 239000013642 negative control Substances 0.000 claims abstract description 7
- 241000283690 Bos taurus Species 0.000 claims abstract description 6
- 239000002158 endotoxin Substances 0.000 claims abstract description 5
- 230000003053 immunization Effects 0.000 claims abstract description 5
- 229920006008 lipopolysaccharide Polymers 0.000 claims abstract description 4
- 238000002965 ELISA Methods 0.000 claims description 58
- 238000002360 preparation method Methods 0.000 claims description 46
- 238000010790 dilution Methods 0.000 claims description 34
- 239000012895 dilution Substances 0.000 claims description 34
- 238000012856 packing Methods 0.000 claims description 23
- 210000004027 cell Anatomy 0.000 claims description 20
- 238000004519 manufacturing process Methods 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 238000007789 sealing Methods 0.000 claims description 14
- 241000894006 Bacteria Species 0.000 claims description 12
- 230000001580 bacterial effect Effects 0.000 claims description 12
- 206010003445 Ascites Diseases 0.000 claims description 11
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 11
- 210000004408 hybridoma Anatomy 0.000 claims description 11
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000000853 adhesive Substances 0.000 claims description 8
- 230000001070 adhesive effect Effects 0.000 claims description 8
- 239000000872 buffer Substances 0.000 claims description 8
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 claims description 8
- 238000007865 diluting Methods 0.000 claims description 8
- 238000004108 freeze drying Methods 0.000 claims description 8
- 230000036039 immunity Effects 0.000 claims description 8
- 208000015181 infectious disease Diseases 0.000 claims description 8
- 238000007689 inspection Methods 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 7
- 238000007796 conventional method Methods 0.000 claims description 7
- 230000036541 health Effects 0.000 claims description 7
- 238000001556 precipitation Methods 0.000 claims description 7
- 239000011780 sodium chloride Substances 0.000 claims description 7
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 6
- 241000588724 Escherichia coli Species 0.000 claims description 6
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims description 6
- 229930182566 Gentamicin Natural products 0.000 claims description 6
- 241000607447 Yersinia enterocolitica Species 0.000 claims description 6
- 238000010241 blood sampling Methods 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 229960002518 gentamicin Drugs 0.000 claims description 6
- 239000002504 physiological saline solution Substances 0.000 claims description 6
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 238000003908 quality control method Methods 0.000 claims description 6
- 238000000967 suction filtration Methods 0.000 claims description 6
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 6
- 229940033663 thimerosal Drugs 0.000 claims description 6
- 229940098232 yersinia enterocolitica Drugs 0.000 claims description 6
- 230000004523 agglutinating effect Effects 0.000 claims description 5
- 230000009849 deactivation Effects 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 238000004448 titration Methods 0.000 claims description 5
- 241001481665 Protophormia terraenovae Species 0.000 claims description 4
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 4
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 4
- 235000019800 disodium phosphate Nutrition 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000011521 glass Substances 0.000 claims description 4
- 238000002649 immunization Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 4
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 230000002277 temperature effect Effects 0.000 claims description 4
- 229920001817 Agar Polymers 0.000 claims description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- 238000009007 Diagnostic Kit Methods 0.000 claims description 3
- 241000699670 Mus sp. Species 0.000 claims description 3
- 239000004793 Polystyrene Substances 0.000 claims description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 3
- 244000061456 Solanum tuberosum Species 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 239000005030 aluminium foil Substances 0.000 claims description 3
- 238000004500 asepsis Methods 0.000 claims description 3
- 229940098773 bovine serum albumin Drugs 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 239000002274 desiccant Substances 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 230000003203 everyday effect Effects 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 238000011081 inoculation Methods 0.000 claims description 3
- 239000007927 intramuscular injection Substances 0.000 claims description 3
- 238000010255 intramuscular injection Methods 0.000 claims description 3
- 239000007928 intraperitoneal injection Substances 0.000 claims description 3
- 238000002372 labelling Methods 0.000 claims description 3
- 239000000155 melt Substances 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- 230000001902 propagating effect Effects 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 239000001632 sodium acetate Substances 0.000 claims description 3
- 235000017281 sodium acetate Nutrition 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000009461 vacuum packaging Methods 0.000 claims description 3
- 239000000273 veterinary drug Substances 0.000 claims description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 2
- 230000001186 cumulative effect Effects 0.000 claims description 2
- 239000008367 deionised water Substances 0.000 claims description 2
- 229910021641 deionized water Inorganic materials 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000001117 sulphuric acid Substances 0.000 claims description 2
- 235000011149 sulphuric acid Nutrition 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 239000003643 water by type Substances 0.000 claims description 2
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 abstract description 17
- 230000002265 prevention Effects 0.000 abstract description 4
- 238000008157 ELISA kit Methods 0.000 abstract description 3
- 238000003771 laboratory diagnosis Methods 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 102000004169 proteins and genes Human genes 0.000 abstract description 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 2
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 239000012089 stop solution Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 13
- 230000002860 competitive effect Effects 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 8
- 239000008267 milk Substances 0.000 description 7
- 210000004080 milk Anatomy 0.000 description 7
- 235000013336 milk Nutrition 0.000 description 7
- 229960005486 vaccine Drugs 0.000 description 7
- 238000011160 research Methods 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000000405 serological effect Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- 230000001900 immune effect Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 241001148106 Brucella melitensis Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 229940038698 brucella melitensis Drugs 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000002875 fluorescence polarization Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 230000010287 polarization Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- IICCLYANAQEHCI-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 IICCLYANAQEHCI-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 241000589567 Brucella abortus Species 0.000 description 1
- 241001148111 Brucella suis Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010029719 Nonspecific reaction Diseases 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229940056450 brucella abortus Drugs 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000001085 differential centrifugation Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 210000004332 phalangeal cell Anatomy 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 208000030133 remittent fever Diseases 0.000 description 1
- 229930187593 rose bengal Natural products 0.000 description 1
- 229940081623 rose bengal Drugs 0.000 description 1
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910071634 CN101581726B (zh) | 2009-03-26 | 2009-03-26 | 新一代布鲁氏菌病抗体竞争酶联免疫吸附试验检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910071634 CN101581726B (zh) | 2009-03-26 | 2009-03-26 | 新一代布鲁氏菌病抗体竞争酶联免疫吸附试验检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101581726A CN101581726A (zh) | 2009-11-18 |
CN101581726B true CN101581726B (zh) | 2013-06-12 |
Family
ID=41363966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200910071634 Active CN101581726B (zh) | 2009-03-26 | 2009-03-26 | 新一代布鲁氏菌病抗体竞争酶联免疫吸附试验检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101581726B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102391993B (zh) * | 2011-11-16 | 2013-12-18 | 中国人民解放军疾病预防控制所 | 布鲁氏菌检测用杂交瘤细胞株17c8及其产生的单克隆抗体 |
CN102680681A (zh) * | 2012-05-25 | 2012-09-19 | 北京金豪制药股份有限公司 | 一种i型人类免疫缺陷病毒(hiv-1)新发感染酶免检测试剂盒 |
CN103278635B (zh) * | 2013-05-31 | 2014-10-22 | 中国兽医药品监察所 | 动物布鲁氏菌病竞争elisa 抗体检测试剂盒 |
CN103344770B (zh) * | 2013-07-15 | 2015-09-23 | 山东省农业科学院奶牛研究中心 | 牛布鲁氏菌间接elisa检测试剂盒 |
CN107475347A (zh) * | 2017-10-12 | 2017-12-15 | 天康生物股份有限公司 | 一种快速分析布氏菌菌株变异率的方法 |
CN108812548A (zh) * | 2018-09-19 | 2018-11-16 | 天康生物股份有限公司 | 布鲁氏菌疫苗免疫牛的方法和用途 |
CN112611864B (zh) * | 2020-12-03 | 2024-03-12 | 重庆市畜牧科学院 | 筛分病菌模型的***及筛分方法 |
CN113281502B (zh) * | 2021-05-14 | 2024-02-02 | 遵义医科大学附属医院 | 一种酶联免疫吸附试验模拟方法 |
CN117538549A (zh) * | 2023-09-27 | 2024-02-09 | 上海交通大学医学院附属瑞金医院 | 一种评估血浆置换清除dsa临床疗效的预测体系 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1632585A (zh) * | 2004-04-02 | 2005-06-29 | 中国人民解放军军事医学科学院微生物流行病研究所 | 一种检测布鲁氏菌感染的免疫层析试纸及其制备方法 |
-
2009
- 2009-03-26 CN CN 200910071634 patent/CN101581726B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1632585A (zh) * | 2004-04-02 | 2005-06-29 | 中国人民解放军军事医学科学院微生物流行病研究所 | 一种检测布鲁氏菌感染的免疫层析试纸及其制备方法 |
Non-Patent Citations (2)
Title |
---|
Anastasios Minas等.《Validation of a competitive ELISA for diagnosis of Brucella melitensis infection in sheep and goats》.《The veterinary Journal》.2008,第177卷(第3期),材料和方法部分,尤其是竞争ELISA部分. * |
张东林等.《蛋白AG检测多种弓形虫抗体AG-ELISA的效果评价》.《湖北农业科学》.2008,第47卷(第6期),1.6节. * |
Also Published As
Publication number | Publication date |
---|---|
CN101581726A (zh) | 2009-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101581726B (zh) | 新一代布鲁氏菌病抗体竞争酶联免疫吸附试验检测试剂盒 | |
CN101592661B (zh) | 布鲁氏菌病抗体竞争酶联免疫吸附试验检测试剂盒 | |
CN102662059B (zh) | 一种用于测定幽门螺杆菌抗体的胶乳增强免疫比浊试剂盒及其制备方法和应用 | |
CN100482787C (zh) | 检测磺胺嘧啶残留的免疫胶体金试纸条及其制备方法 | |
CN101592660B (zh) | 布鲁氏菌病间接酶联免疫吸附试验奶液抗体检测试剂盒 | |
CN101738473B (zh) | ***抗体诊断试剂盒及其制备方法 | |
CN106556701B (zh) | 羊布鲁氏菌间接elisa抗体检测试剂盒 | |
CN101799470A (zh) | 布鲁氏菌病间接酶联免疫吸附试验抗体检测试剂盒 | |
CN105067812A (zh) | 牛布鲁氏菌间接elisa抗体检测试剂盒 | |
CN105137073A (zh) | 牛布鲁氏菌胶体金抗体检测试纸条 | |
CN106771182A (zh) | 牛布鲁氏菌IgM亚型抗体间接ELISA检测试剂盒 | |
CN105866407A (zh) | 一种曲霉菌半乳甘露聚糖抗原免疫检测试剂盒及其制备方法与应用 | |
CN105277711B (zh) | 一种用于检测he4的酶联免疫试剂盒 | |
CN102621304A (zh) | 鹿布氏杆菌病间接酶联免疫吸附检测法 | |
ES2691260T3 (es) | Componentes de pared celular de levadura y detección de los mismos | |
Boraker et al. | BrucELISA: an enzyme-antibody immunoassay for detection of Brucella abortus antibodies in milk: correlation with the Brucella ring test and with shedding of viable organisms | |
US20240044891A1 (en) | Antibody detection test strip of integrating primary screening and diagnosis of sheep brucellosis | |
US20240044890A1 (en) | Antibody detection test strip of integrating primary screening and diagnosis of bovine brucellosis | |
CN102809653B (zh) | 一种检测新布尼亚病毒抗原的elisa试剂盒的制备和应用 | |
CN107656057A (zh) | 一种用于检测布鲁氏杆菌病IgM抗体的ELISA试剂盒及其应用 | |
CN108048408A (zh) | 牛单核细胞趋化蛋白-1杂交瘤细胞株、其分泌的单克隆抗体及应用 | |
CN101846681A (zh) | 动物布鲁氏菌病荧光偏振检测法-fpa抗体检测试剂盒 | |
CN1279358C (zh) | 一种检测布鲁氏菌感染的免疫层析试纸及其制备方法 | |
EP4235178A2 (en) | Crude native hapten-based indirect elisa assay kit and lyophilised controls for the confirmatory diagnosis of bovine brucellosis in blood serum and milk by animal and tank | |
CN105759054B (zh) | 一种用于检测牛布鲁菌病的elispot检测试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191216 Address after: 150070 4 / F, unit 4, No.5, Taihu North Street, Chuangye building, Yingbin Road, high tech Industrial Development Zone, Daoli District, Harbin City, Heilongjiang Province Co-patentee after: Pinghe Institute of biotechnology, Heilongjiang Province Patentee after: Harbin Pinghe Biotechnology Co., Ltd. Co-patentee after: Zhang Xiaoyan Address before: 150070 building 205, comprehensive building, Yingbin Road, Harbin Development Zone, Harbin, Heilongjiang Patentee before: Zhang Xiaoyan |
|
TR01 | Transfer of patent right |